SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-17-004677
Filing Date
2017-05-05
Accepted
2017-05-05 16:30:58
Documents
5

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs32017_soligenixinc.htm S-3 361659
2 OPINION OF DUANE MORRIS LLP fs32017ex5i_soligenixinc.htm EX-5.1 38443
3 CONSENT OF EISNERAMPER LLP fs32017ex23i_soligenixinc.htm EX-23.1 2991
4 GRAPHIC image_001.jpg GRAPHIC 7425
5 GRAPHIC image_002.jpg GRAPHIC 17001
  Complete submission text file 0001213900-17-004677.txt   438264
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-217738 | Film No.: 17818810
SIC: 2834 Pharmaceutical Preparations